King L A, Tase T, Twiggs L B, Okagaki T, Savage J E, Adcock L L, Prem K A, Carson L F
Department of Obstetrics and Gynecology, University of Minnesota Medical School, Minneapolis.
Cancer. 1989 Mar 1;63(5):897-900. doi: 10.1002/1097-0142(19890301)63:5<897::aid-cncr2820630517>3.0.co;2-w.
Cases of invasive carcinoma of the uterine cervix were analyzed to determine whether the presence or absence of human papillomavirus (HPV) DNA in the neoplasms was a contributing factor to their outcome. The presence of HPV DNA was evaluated using in situ hybridization on formalin-fixed, paraffin-embedded tissue sections. Eighty-five patients with cervical carcinoma who had been surgically evaluated were included in the study. Data from these patients was analyzed retrospectively to determine survival, recurrence, presence of nodal metastases, tumor grade, mode of therapy, peritoneal fluid cytologic results, and age in relation to presence or absence of HPV DNA. No significant statistical differences were found between the HPV-16-positive, HPV-18-positive, and HPV DNA-negative patients.
对子宫颈浸润癌病例进行分析,以确定肿瘤中人类乳头瘤病毒(HPV)DNA的有无是否是影响其预后的一个因素。采用原位杂交技术对福尔马林固定、石蜡包埋的组织切片进行HPV DNA检测。85例经手术评估的宫颈癌患者纳入本研究。对这些患者的数据进行回顾性分析,以确定与HPV DNA有无相关的生存率、复发率、淋巴结转移情况、肿瘤分级、治疗方式、腹水细胞学检查结果及年龄。HPV - 16阳性、HPV - 18阳性和HPV DNA阴性患者之间未发现显著的统计学差异。